01 1Grunenthal GmbH
01 1BC World Pharmaceutical Co., Ltd.
01 1tapentadol hydrochloride
01 1Germany
Registrant Name : BC World Pharmaceutical Co., Ltd.
Registration Date : 2015-11-11
Registration Number : Su4945-23-ND
Manufacturer Name : Grunenthal GmbH
Manufacturer Address : Zieglerstrabe 6, 52078 Aachen, Germany
90
PharmaCompass offers a list of Tapentadol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tapentadol manufacturer or Tapentadol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tapentadol manufacturer or Tapentadol supplier.
A Palexia manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Palexia, including repackagers and relabelers. The FDA regulates Palexia manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Palexia API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Palexia manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Palexia supplier is an individual or a company that provides Palexia active pharmaceutical ingredient (API) or Palexia finished formulations upon request. The Palexia suppliers may include Palexia API manufacturers, exporters, distributors and traders.
click here to find a list of Palexia suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Palexia Drug Master File in Korea (Palexia KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Palexia. The MFDS reviews the Palexia KDMF as part of the drug registration process and uses the information provided in the Palexia KDMF to evaluate the safety and efficacy of the drug.
After submitting a Palexia KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Palexia API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Palexia suppliers with KDMF on PharmaCompass.
